Disha Pharmaceutical Group which has 10 subsidiaries and has more than 2,000 employees and a total asset value of over RMB 835 million (approximately US$129 million) is situated in Weihai City, a picturesque coastal city in China. DeJun Wang who borrowed RMB 500000 and led three persons to build the predecessorn of Disha Pharmaceutical Group in 1993. It was licensed to be National pharmaceutical Group in 2002 and has four production bases, including western medicine preparation, active pharmaceutical ingredients, chinese traditional patent medicine and protective food.

So far, through 18 years' development, Disha Pharmaceutical Group covers a manufacturing area of 140000 square meters including High standard preparation workshop and API workshop with an area of 20,000 square meters that both obtained the cGMP Certificate. It currently produces more than 50 types of medical products with more than 100 specifications, which are famous in overcoming Diabetes mellitus, Hypertension, Hypopepsia and Inflammation. Some kinds of products gained Shandong Famous Product more than once and in 2011 DiSha Group was grant with China well-know trademark.

Ranking in The China's pharmaceutical industry Top100, in 2010 The Disha Pharmaceutical Group achieved sales revenue of RMB 1.69 billion and aim at that sales revenue will reach RMB 3 billion in 2013 and become national large-scale Pharmaceutical Group in 2015 with 10 billion sales proceeds.

Adhering to the concept of people-oriented concept ,Disha Pharmaceutial Group in exploring a scientific and healthy development model.Disha is well-positioned to continuing serving the medical community and improve people’s health for generations to come.